Clinical Trials in Atlanta

Showing 9221-9240 of 19,805 trials

Frameshift Peptides of Children With NF1

NCT04212351

The objective of this study is to determine if children and young adults with Neurofibromatosis Type 1 (NF1) and either Low Grade Gliomas (LGGs) or Plexiform Neurofibromas (PNs) have a specific frameshift peptide protein profile and whether a disease specific vaccine created to address these frameshift mutations and variants can be developed. Three study populations will be analyzed; patients with NF1 and active LGGs, NF1 and active PNs, and NF1 and no evidence of active LGGs or PNs. Participation involves a onetime blood draw.

Neurofibromatosis Type 1

Children's National Research Institute60 participantsStarted Apr 2019

Washington D.C., District of Columbia, United States • Atlanta, Georgia, United States • Dallas, Texas, United States

COMPLETEDPhase 2< 1 mile

A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease

NCT02891226

The purpose of this study is to evaluate the safety and effectiveness of the study drug Mirikizumab in participants with active Crohn's Disease.

Crohn's Disease

Eli Lilly and Company191 participantsStarted Dec 2016

Huntsville, Alabama, United States • Tucson, Arizona, United States • Garden Grove, California, United States +105 more locations

Frameshift Peptides of Children With NF1

A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease

Find Trials by Condition in Atlanta

Growth and Development Study of Alglucosidase Alfa

Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)

Post Approval Study: NOVATION Ceramic Articulation Hip System

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

A Prospective Study of Early Mechanical Stabilization and Bleeding in Disruption of the Pelvic Ring

A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Evaluation of the Use of Medical Scribes in VAMC Emergency Departments and Specialty Care Clinics

Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH)

Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis

A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms

A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours